Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
45.04
-1.48 (-3.18%)
Nov 20, 2024, 4:00 PM EST - Market closed
Apogee Therapeutics Market Cap
Apogee Therapeutics has a market cap or net worth of $2.56 billion as of November 21, 2024. Its market cap has increased by 196.46% in one year.
Market Cap
2.56B
Enterprise Value
1.82B
1-Year Change
196.46%
Ranking
Category
Stock Price
$45.04
Market Cap Chart
Since the IPO on July 14, 2023, Apogee Therapeutics's market cap has increased from $808.89M to $2.56B, an increase of 216.84%. That is a compound annual growth rate of 134.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 2.56B | 91.03% |
| Dec 29, 2023 | 1.34B | 65.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LifeStance Health Group | 2.68B |
| Concentra Group Holdings Parent | 2.64B |
| PACS Group | 2.63B |
| Vericel | 2.61B |
| Amneal Pharmaceuticals | 2.58B |
| SpringWorks Therapeutics | 2.57B |
| Iovance Biotherapeutics | 2.57B |
| Belite Bio | 2.53B |